Abstract
Flexible docking simulations were performed on two series of 4-thiazolidinones as HIV-1 reverse transcriptase (HIV-1 RT) inhibitors. This was done by analyzing the interaction of these compounds with the allosteric site of the HIV-1 reverse transcriptase enzyme. The binding scores for these compounds were also congruent with their anti-HIV activity. A good correlation between the predicted binding free energies and the experimentally observed inhibitory activities (EC50) suggest that the identified binding conformations of these inhibitors are reliable. The results of docking studies provide an insight into the pharmacophoric structural requirements for the HIV-1 RT inhibitory activity of this class of molecules.
Similar content being viewed by others
References
De Clercq E (2005) J Med Chem 10:1297–1313
Schafer W, Friebe WG, Leinert M, Merttens A, Poll T, von der Saal W, Zilch H, Nuber H, Ziegler ML (1993) J Med Chem 36:726–732
Barreca ML, Balzarini J, Chimirri A, De Clercq E, Luca LD, Holtje MH, Holtje M, Monforte AM, Monforte P, Pannecouque C, Rao A, Zappala M (2002) J Med Chem 45:5410–5413
Rao A, Balzarini J, Carbone A, Chimirri A, De Clercq E, Monforte AM, Monforte P, Pannecouque C, Zappala M (2004) Antiviral Res 63:79–84
Prabhakar YS, Solomon VR, Rawal RK, Gupta MK, Katti SB (2004) QSAR & Combi Sci 23:234–244
Rawal RK, Solomon VR, Prabhakar YS, Katti SB, De Clercq E (2005) Comb Chem High Throughput Screen 8:439–443
Roy K, Leonard T (2005) QSAR & Comb Sci 24:579–592
Barreca ML, Balzarini J, Chimirri A, De Clercq E, Luca LD, Holtje MH, Holtje M, Monforte AM, Monforte P, Pannecouque C, Rao A, Zappala M (2002) J Med Chem 45:5410–5413
Prabhakar YS, Rawal RK, Gupta MK, Solomon VR, Katti SB (2005) Comb Chem High Throughput Screen 8:431–437
InsightII 2000.1 Program (2000) Accelrys Inc, San Diego, California
Sybyl 7.0 (2004) TRIPOS Inc, 1699 South Hanley Road, St. Louis, Missouri 63144, USA
Gasteiger J, Marsili M (1980) Tetrahedron 36:3219–3228
FlexX, version 1.13.5 (2004) BioSolveIT GmbH, Saint Augustin, Germany
Rarey M, Kramer B, Lengauer T, Klebe G (1996) J Mol Biol 261:470–489
Frankel EN, Waterhouse AL, Kinsella JE (1993) Lancet 341:1103–1104
Ren J, Esnouf R, Hopkins A, Ross C, Jones Y, Stammers D, Stuart D (1995) Structure 3:915–926
Ren J, Milton J, Weaver KL, Short SA, Stuart DI, Stammers DK (2000) Structure 8:1089–1094
Ren J, Esnouf R, Garman E, Somers D, Ross C, Kirby I, Keeling J, Darby G, Jones Y, Stuart D (1995) Nat Struct Biol 2:293–302
Böhm HJ (1998) J Comput Aided Mol Des 12:309
Eldridge MD, Murray CW, Auton TR, Paolini GV, Mee RP (1997) J Comput Aided Mol Des 11:425–445
Ewing TJA, Kuntz ID (1997) J Comput Chem 18:1175–1189
Jones G, Willett P, Glen RC, Leach AR, Taylor R (1997) J Mol Biol 267:727–748
Muegge I, Martin YC (1999) J Med Chem 42:791–804
Mager PP (1997) Med Res Rev 17:235–276
Tantillo C, Ding J, Jacobo-Molina A, Nanni RG, Boyer PL, Hughes SH, Pauwels R, Andries K, Janssen PA, Arnold E (1994) J Mol Biol 243:369–387
Barreca, ML, Rao A, De Luca L, Zappala M, Monforte AM, Maga G, Pannecouque C, Balzarini J, De Clercq E, Chimirri A, Monforte P (2005) J Med Chem 48:3433–3437
Ding J, Das K, Moereels H, Koymans L, Andries K, Janssen PA, Hughes SH, Arnold E (1995) Nat Struct Biol 92:407–415
Das K, Levi PJ, Hughes SH, Arnold E (2005) Prog Biophys Mol Biol 88:209–231
Acknowledgments
This work was supported by Council of Scientific and Industrial Research (CSIR) funded network project CMM0017–Drug target development using in silico biology. The authors acknowledge Dr. Y.S. Prabhakar for critical reading of the manuscript. A.K. acknowledges CSIR for fellowship. C.D.R.I. communication no. of this manuscript is 6853.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rawal, R.K., Kumar, A., Siddiqi, M.I. et al. Molecular docking studies on 4-thiazolidinones as HIV-1 RT inhibitors. J Mol Model 13, 155–161 (2007). https://doi.org/10.1007/s00894-006-0138-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00894-006-0138-7